October 21, 2014 10:33 AM ET

Chemicals

Company Overview of Verdezyne, Inc.

Executive Profile

Richard H. Lathrop Ph.d.

Member of Scientific Advisory Board, Verdezyne, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Richard H. Lathrop, Rick is a Founder and Member of Scientific Advisory Board of Verdezyne, Inc. Dr. Lathrop was a co-founding scientist of Arris Pharmaceutical Corp., and served on the Scientific Advisory Boards of CombiChem, Inc., and GeneFormatics, Inc. Arris went public with 59 full-time employees and a valuation of approximately 60 million dollars in Nov., 1993, then merged with Sequana to form AxyS Pharmaceuticals in Jan., 1998, which was acquired by Celera Therapeutics ...

Corporate Headquarters

2715 Loker Avenue West
Carlsbad, California 92010

United States

Phone: 760-707-5200
Fax: 760-707-5100

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Massachusetts Institute of Technology
BA
Reed College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Verdezyne, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.